Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioVaxys Technology (BVAXF)
OTHER OTC:BVAXF
Holding BVAXF?
Track your performance easily
BVAXF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.03 - $0.08
Previous CloseN/A
Volume36.00K
Average Volume (3M)567.17K
Market Cap
$11.51M
Enterprise Value$13.90M
Total Cash (Recent Filing)$15.65K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.93
Next Earnings
Feb 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding256,026,000
10 Day Avg. Volume380,863
30 Day Avg. Volume567,167
Standard Deviation0.87
R-Squared0.08
Alpha0.09
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-10.40
P/FCF Ratio0.00
Enterprise Value/Market Cap1.21
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-2.85
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BioVaxys Technology News
PremiumCompany Announcements
BioVaxys Advances DPX Technology for mRNA Vaccine Delivery
PremiumCompany Announcements
BioVaxys Technology to Present at Emerging Growth Conference
PremiumCompany Announcements
BioVaxys Completes Third Tranche of Private Placement and Settles Debt
PremiumCompany Announcements
BioVaxys Closes Second Tranche, Raises $175,000
PremiumCompany Announcements
BioVaxys Secures Key Supply to Boost Vaccine ProductionPremiumCompany Announcements
BioVaxys Adjusts Private Placement Pricing StrategyPremiumCompany Announcements
BioVaxys Showcases Promising DPX Platform Data
PremiumCompany Announcements
BioVaxys and SpayVac Boost Vaccine Production CapacityOptions Prices
Currently, No data available
---
Ownership Overview
11.41% Insiders
<0.01% Other Institutional Investors
88.59% Public Companies and
Individual Investors
BVAXF FAQ
What was BioVaxys Technology’s price range in the past 12 months?
BioVaxys Technology lowest stock price was $0.03 and its highest was $0.07 in the past 12 months.
What is BioVaxys Technology’s market cap?
BioVaxys Technology’s market cap is $11.51M.
When is BioVaxys Technology’s upcoming earnings report date?
BioVaxys Technology’s upcoming earnings report date is Feb 26, 2025 which is in 37 days.
How were BioVaxys Technology’s earnings last quarter?
BioVaxys Technology released its earnings results on Sep 27, 2024. The company reported -$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.003.
Is BioVaxys Technology overvalued?
According to Wall Street analysts BioVaxys Technology’s price is currently Overvalued.
Does BioVaxys Technology pay dividends?
BioVaxys Technology does not currently pay dividends.
What is BioVaxys Technology’s EPS estimate?
BioVaxys Technology’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioVaxys Technology have?
BioVaxys Technology has 256,026,000 shares outstanding.
What happened to BioVaxys Technology’s price movement after its last earnings report?
BioVaxys Technology reported an EPS of -$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -20%.
Which hedge fund is a major shareholder of BioVaxys Technology?
Currently, no hedge funds are holding shares in BVAXF
---
Company Description
BioVaxys Technology
Lions Bay Mining Corp is a Canada based mineral exploration company. The company currently retains five mineral properties, with four in the Yukon Canada and one in Nevada. The Yukon properties include the, HY Jay, VM, VBA and Big properties and the Nevada property is located at Fish Lake in Esmeralda County.
---
Technical Analysis
CASI Pharmaceuticals
―
Cyclo Therapeutics
―
Immutep
―
OncoCyte
―
PAVmed
―
Sorrento Therapeutics
―
---